Table 2.
Biomarkers related to different reocclusion lengths in the elderly patients with very long stent implantations.
| Without coronary reocclusion n = 61 | Reocclusion length 4-10 mm n = 67 | Reocclusion length 11-20 mm n = 66 | Reocclusion length 21-35 mm n = 54 | Reocclusion length 36-47 mm n = 53 |
|
|---|---|---|---|---|---|
| ACR (nmol/mL) | 0.9 ± 0.2 | 1.4 ± 0.9∗ | 3.9 ± 1.4∗∗ | 7.0 ± 3.2∗∗∗ | 11.4 ± 4.5∗∗∗∗ |
| MDA (nmol/L) | 3.5 ± 1.4 | 4.9 ± 1.7∗ | 6.7 ± 2.9∗∗ | 8.5 ± 3.7∗∗∗ | 12.0 ± 4.9∗∗∗∗ |
| hs-CRP (mg/L) | 2.7 ± 0.8 | 3.9 ± 0.9∗ | 6.1 ± 1.3∗∗ | 10.2 ± 3.0∗∗∗ | 14.9 ± 4.2∗∗∗∗ |
| TNF-α (ng/L) | 20.1 ± 6.2 | 31.0 ± 6.9∗ | 51.3 ± 7.6∗∗ | 62.9 ± 7.9∗∗∗ | 90.8 ± 8.2∗∗∗∗ |
| SOD3 (U/mL) | 17.0 ± 3.0 | 15.1 ± 2.6∗ | 12.9 ± 1.7∗∗ | 9.9 ± 0.8∗∗∗ | 5.0 ± 0.6∗∗∗∗ |
| PON-1 (U/L) | 157.4 ± 63.5 | 130.7 ± 59.2∗ | 107.0 ± 50.1∗∗ | 87.9 ± 45.6∗∗∗ | 40.2 ± 37.2∗∗∗∗ |
| eNOS (pg/mL) | 59.7 ± 23.5 | 50.5 ± 20.9∗ | 32.9 ± 18.7∗∗ | 22.8 ± 11.0∗∗∗ | 18.9 ± 9.0∗∗∗∗ |
| SDF-1α (ng/L) | 18.1 ± 4.3 | 17.9 ± 4.0∗ | 14.9 ± 3.2∗∗ | 10.0 ± 2.6∗∗∗ | 7.1 ± 1.2∗∗∗∗ |
∗ P < 0.001 (without coronary reocclusion group/reocclusion length 4-10 mm group). ∗∗P < 0.001 (reocclusion length 4-10 mm group/reocclusion length 11-20 mm group). ∗∗∗P < 0.001 (reocclusion length 11-20 mm group/reocclusion length 21-35 mm group). ∗∗∗∗P < 0.001 (reocclusion length 21-35 mm group/reocclusion length 36-47 mm group).